Page last updated: 2024-08-23

paroxetine and Abnormality, Heart

paroxetine has been researched along with Abnormality, Heart in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (48.00)29.6817
2010's12 (48.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC1
Blackwell, KA; Forray, A; Glover, J; Yonkers, KA1
Aydin, B; Beken, S; Dilli, D; Dinlen, N; Okumuş, N; Zenciroğlu, A1
Bérard, A; Boukhris, T; Chaabane, S; Iessa, N; Muanda, FT; Zhao, JP1
Bérard, A; Boukhris, T; Chaabane, S; Muanda, FT; Zhao, J1
Avgil, M; Clementi, M; Di Gianantonio, E; Diav-Citrin, O; Ornoy, A; Schaefer, C; Shechtman, S; Wajnberg, R; Weber-Schoendorfer, C; Weinbaum, D1
Einarson, A; Einarson, TR; Koren, G; O'Brien, L; Sarkar, M1
Jureidini, J; Mintzes, B1
Ephross, SA; Olshan, AF; Poole, C; Wurst, KE1
Tanne, JH2
Bérard, A1
Scialli, AR1
Einarson, A; Koren, G2
Einarson, A2
Aoun, J; Gorsane, MA; Krebs, MO; Soufia, M1
Bérard, A; Crespin, S; Damase-Michel, C; Sheehy, O1
Källén, B; Otterblad Olausson, P1
Cuzzell, JZ1
Hallberg, P; Odlind, V; Sjöblom, V1
Bérard, A; Blais, L; Oraichi, D; Ramos, E; Rey, E; St-André, M1
DeSantis, M; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Paulus, WD; Pistelli, A1

Reviews

7 review(s) available for paroxetine and Abnormality, Heart

ArticleYear
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review.
    Acta psychiatrica Scandinavica, 2020, Volume: 141, Issue:1

    Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors

2020
Antidepressant use in pregnant and postpartum women.
    Annual review of clinical psychology, 2014, Volume: 10

    Topics: Antidepressive Agents; Depression, Postpartum; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects

2014
The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    British journal of clinical pharmacology, 2016, Volume: 81, Issue:4

    Topics: Abnormalities, Drug-Induced; Female; Heart Defects, Congenital; Humans; Maternal Exposure; Paroxetine; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Selective Serotonin Reuptake Inhibitors

2016
Does paroxetine cause cardiac malformations?
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2008, Volume: 30, Issue:8

    Topics: Case-Control Studies; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors

2008
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
    Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors

2010
[SSRIs and pregnancy: a review of the literature].
    L'Encephale, 2010, Volume: 36, Issue:6

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Newborn, Diseases; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk Assessment; Selective Serotonin Reuptake Inhibitors

2010
Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Bias; Causality; Compensation and Redress; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Drug Utilization; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Publishing; Risk Factors; Selective Serotonin Reuptake Inhibitors

2012

Other Studies

18 other study(ies) available for paroxetine and Abnormality, Heart

ArticleYear
Treacher Collins syndrome with multiple congenital heart defects after paroxetine exposure: case report.
    Genetic counseling (Geneva, Switzerland), 2014, Volume: 25, Issue:1

    Topics: Abnormalities, Multiple; Adult; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Mandibulofacial Dysostosis; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors

2014
Paroxetine use during pregnancy and the risk of cardiac defects.
    British journal of clinical pharmacology, 2016, Volume: 82, Issue:2

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors

2016
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:5

    Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Antidepressive Agents, Second-Generation; Birth Weight; Case-Control Studies; Confidence Intervals; Drug Administration Schedule; Female; Fluoxetine; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Maternal Age; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors

2008
Should paroxetine be used to treat depression during pregnancy?
    The American journal of psychiatry, 2008, Volume: 165, Issue:11

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome

2008
GSK is sued in US over alleged link of paroxetine to birth defects.
    BMJ (Clinical research ed.), 2009, Oct-12, Volume: 339

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Drug Industry; Heart Defects, Congenital; Humans; Infant; Male; Paroxetine; Teratogens; United States

2009
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.
    BMJ (Clinical research ed.), 2009, Oct-15, Volume: 339

    Topics: Antidepressive Agents, Second-Generation; Child, Preschool; Compensation and Redress; Depressive Disorder; Drug Industry; Female; Heart Defects, Congenital; Humans; Male; Paroxetine; Philadelphia; Pregnancy; Pregnancy Complications

2009
Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?
    Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3

    Topics: Abnormalities, Drug-Induced; Adult; Data Interpretation, Statistical; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty

2010
Paroxetine exposure during pregnancy and cardiac malformations.
    Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Mice; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Rabbits; Rats; Selective Serotonin Reuptake Inhibitors; Species Specificity; Uncertainty

2010
First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.
    Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:7

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors

2010
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
    Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:8

    Topics: Abnormalities, Drug-Induced; Adult; Depression; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty

2010
Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
    Current drug safety, 2012, Volume: 7, Issue:3

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; France; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prevalence; Quebec

2012
Antidepressant drugs during pregnancy and infant congenital heart defect.
    Reproductive toxicology (Elmsford, N.Y.), 2006, Volume: 21, Issue:3

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Clomipramine; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Sweden

2006
Paroxetine may increase risk for congenital malformations.
    Dermatology nursing, 2006, Volume: 18, Issue:1

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Trimester, First; Teratogens

2006
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Abnormalities, Drug-Induced; Confounding Factors, Epidemiologic; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Mental Disorders; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors

2006
Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
    Canadian family physician Medecin de famille canadien, 2006, Volume: 52

    Topics: Canada; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Paroxetine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors

2006
SSRI antidepressants and birth defects.
    Prescrire international, 2006, Volume: 15, Issue:86

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Denmark; Depression; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Sweden; Teratogens; United States

2006
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2007, Volume: 80, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Middle Aged; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors

2007
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    The American journal of psychiatry, 2008, Volume: 165, Issue:6

    Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Risk Assessment

2008